Target Validation to Biomarker Development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF03256271.pdf
Reference73 articles.
1. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004; 3(8): 711–5
2. Same old story? Nat Rev Drug Discov 2007; 6 (2): 97
3. Collins I, Workman P. New approaches to molecular cancer therapeutics. Nat Chem Biol 2006; 2(12): 689–700
4. Benson JD, Chen YN, Cornell-Kennon SA, et al. Validating cancer drug targets. Nature 2006; 441(7092): 451–6
5. Sawyers CL. Opportunities and challenges in the development of kinase inhibitor therapy for cancer. Genes Dev 2003; 17(24): 2998–3010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ATAD2 in cancer: a pharmacologically challenging but tractable target;Expert Opinion on Therapeutic Targets;2017-11-23
2. Development: In Vivo Pharmacology—Systems Biology in Health and Disease II;Systems Biology in Biotech & Pharma;2012
3. Constitutive Expression of Short Hairpin RNAin VivoTriggers Buildup of Mature Hairpin Molecules;Human Gene Therapy;2011-12
4. Proteomics as a Promising Tool in the Search for 3D Biomarkers;3D Cell-Based Biosensors in Drug Discovery Programs;2010-06-22
5. Molecular and Cellular Concepts in Toxicology;General and Applied Toxicology;2009-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3